House passes' $3T 'HEROES' aid for stimulus checks, rent assistance

Here are the latest coronavirus updates from around the world.
Image:
Truckers protest low rates and lack of broker transparency along Constitution Avenue in Washington on May 15, 2020.Olivier Douliery / AFP - Getty Images

Breaking News Emails

Get breaking news alerts and special reports. The news and stories that matter, delivered weekday mornings.
SUBSCRIBE

The global coronavirus death toll passed 300,000, with more than 4.4 million confirmed cases around the world, according to data from Johns Hopkins University. The U.S. remains the world's worst-hit country, with more than 86,600 deaths.

Friday evening the House passed a $3 trillion coronavirus relief package that would include another round of stimulus payments of up to $1,200 per person. President Donald Trump has suggested he won't support the bill.

Critics Friday said U.S. Immigration and Customs Enforcement is presenting families detained at the border with the choice of allowing children to be released without them or staying together and facing possible virus exposure in detention.

Additionally, the CDC issued a health alert to physicians on a rare but potentially deadly condition linked to COVID-19 in children that has now been reported in at least 19 states and Washington, D.C.

Here's what to know about the coronavirus, plus a timeline of the most critical moments:

Download the NBC News app for latest updates on the coronavirus outbreak.

This live coverage has now ended. Continue reading May 16 coronavirus news.

Convalescent plasma is safe to treat COVID-19, study finds

The most comprehensive national study to date has found that convalescent plasma appears to be safe to use on COVID-19 patients, a promising development in the race to find a treatment for the deadly virus. But the study didn't determine whether the treatment works.

A team of more than 5,000 doctors from over 2,000 hospitals and laboratories have been testing the experimental therapy, which involves transfusing the antibody-rich blood serum of recovered COVID-19 patients into people who are battling the illness.

Of the 5,000 seriously ill patients who received blood plasma transfusions for the study, fewer than 1 percent experienced serious adverse events. The mortality rate seven days after treatment was 14.9 percent, but the researchers noted the infusion patients were already gravely ill and the rate "does not appear excessive."

Read the full story here